anti-SSEA3 antibody product blog
Tags: Antibody; Monoclonal Antibody; SSEA3; anti-SSEA3 antibody;
The SSEA3 n/a (Catalog #MBS832799) is an Antibody produced from Rat and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s SSEA3 can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blot (WB). Researchers should empirically determine the suitability of the SSEA3 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the SSEA3 antibody with the following immunoassay(s):
Flow Cytometry (FC/FACS) (Flow cytometric analysis of Jurkat cells using SSEA3 antibody (green) and a negative control antibody (purple))
Rat monoclonal SSEA3 antibody.
Biological Significance: This antibody reacts with the Stage-specific embryonic antigen-3. The epitope is expressed on the surface of human teratocarcinoma stem cells, embryonic carcinoma cells, human embryonic germ cells and human embryonic stem cells. Expression of SSEA-3 diminishes with differentiation of human EC cells. Cross-Reactivity: Human, Mouse
Immunogen: SSEA3 antibody was raised in Rat using 4-8 cell stage mouse embryos as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing SSEA3 are readily searchable from our website. Different antibodies against the same target such as SSEA3 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.